Ketorolac Tromethamine Injection, USP is a potent nonsteroidal anti-inflammatory drug (NSAID) designed for short-term (up to 5 days) management of moderately severe acute pain that requires opioid-level analgesia. It is available for both intravenous (IV) and intramuscular (IM) administration.
Key Benefits:
- Effective Pain Relief: Provides opioid-level analgesia for managing acute pain, particularly in post-operative settings.
- Short-Term Use: Intended for use up to 5 days in adults, ensuring pain relief while minimizing long-term risks associated with NSAID use.
- Multi-Route Administration: Available for both IV and IM administration, offering flexibility based on patient needs.
Dosage and Administration:
- Adults <65 Years of Age: Recommended dose is 30 mg IV or IM every 6 hours, with a maximum daily dose of 120 mg.
- Adults ≥65 Years, Renally Impaired, or Less Than 50 kg: 15 mg every 6 hours, with a maximum daily dose of 60 mg. The combined duration of use of IV/IM and oral ketorolac tromethamine should not exceed 5 days. Transition to oral dosing should occur only after IV or IM administration if necessary.
Why Choose Ketorolac Tromethamine Injection?
- Potent NSAID Action: Effective in providing strong pain relief without the sedative effects associated with opioids.
- Short-Term Efficacy: Ideal for situations where powerful, temporary pain control is required.
- Clinically Tested: Widely used in post-surgical settings for its strong analgesic properties.
Warnings:
- Gastrointestinal Risks: Can cause serious gastrointestinal issues, such as bleeding and ulcers, which may occur without warning.
- Cardiovascular and Renal Risks: Increased risk of cardiovascular events such as myocardial infarction and stroke. Not recommended for patients with advanced renal impairment.
- Bleeding Risk: Contraindicated in patients at high risk of bleeding, those undergoing major surgery, or in labor and delivery.
Disclaimer:
This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
